ITM and Lumara Bio Announce Real-World Re-treatment Data and Dosimetry Results from COMPETE for ¹⁷⁷Luedotreotide (ITM-11) in GEP-NETs at ASTRO 2026

ConferenceITM-11Positive

AI Analysis

Summary

ITM and Lumara Bio presented real-world re-treatment data and dosimetry results for 177Lu-edotreotide (ITM-11) in GEP-NETs patients at ASTRO 2026 Annual Meeting in Boston.

Clinical Trial Data

Outcome Details

Real-world re-treatment data and dosimetry results presented at ASTRO 2026

Importance:5/10

Sentiment:

0.50

radiopharmaceuticaloncologyneuroendocrine tumorsconference presentationclinical data

Related Companies

$ATALF $DFPH $WHEN

Read the original article

Published by GlobeNewswire Clinical Studies on September 27, 2026 8:00 PM

Read Original